INSIGHTS ON CLINICAL TRIAL PARTNERING

• How Strategic LQPPV Outsourcing Future-Proofs PV Compliance In The AI Era

  As health authorities seek standardization across global processes and strong AI governance, working with an experienced PV partner will help minimize the burden of oversight and ensure compliance.

• Why Bioanalysis Needs To Break Free From Manual Bottlenecks

  Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.

• PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form

  Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.

• Establishing Trust With Real People In Clinical Research

  Get actionable strategies to enhance engagement, strengthen relationships, and support study success in clinical research through clear communication, transparency, and ethical practices.

• Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials

  4/11/2025

  Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.

• Finding The Right CRO Partner For Early-Stage Oncology Trials

  11/21/2025

  Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.

• Switching IRT/RTSM Providers Shouldn't Feel Like Moving Mountains | Korio Makes It Easy

  3/25/2026

  Unveil how structured, repeatable processes can turn RTSM migrations from high‑risk undertakings into predictable transitions.

• 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives

  3/12/2026

  AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

• 10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them

  7/1/2025

  Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.